We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UiPath Stock Screams Undervalued as Market Overlooks Its RPA Dominance
Read MoreHide Full Article
Key Takeaways
UiPath's 4.18X forward P/S ratio undercuts the industry average of 5.85X, signaling potential undervaluation.
PATH's RPA platform powers digital shifts in finance, healthcare and logistics with strong recurring revenue.
Partnerships with Microsoft and SAP reinforce PATH's enterprise edge and automation-first growth strategy.
UiPath Inc. (PATH - Free Report) is trading at a discount that growth investors shouldn't ignore. With a forward 12-month price-to-sales (P/S) ratio of just 4.18X — well below the industry average of 5.85X — UiPath looks like a rare undervalued gem in the fast-evolving automation landscape. This disparity isn’t a sign of weakness; rather, it reflects a cautious market that may be underestimating the company’s long-term potential. As a dominant force in robotic process automation (RPA), UiPath is scaling across critical industries like finance, healthcare, and logistics, supported by robust recurring revenue and a rapidly expanding global footprint.
Image Source: Zacks Investment Research
While macro headwinds and tech-sector volatility may be fueling short-term hesitation, PATH’s fundamentals tell a different story. Its deeply integrated developer ecosystem, breadth of automation tools, and enterprise-grade capabilities put it at the center of digital transformation initiatives worldwide. Strategic partnerships with heavyweights like Microsoft and SAP further solidify its relevance and ensure its AI-driven automation suite remains indispensable to large-scale operations.
The Undervalued Challenger Among Giants
Compared to established enterprise players, like ServiceNow (NOW - Free Report) and Pegasystems (PEGA - Free Report) , PATH’s valuation looks strikingly modest. ServiceNow, riding high on profitability and a wide product suite, commands a forward P/S of 13.89X, more than triple UiPath’s. Pegasystems, while similar in automation focus, trades at 4.98X despite slower growth and a narrower automation scope. This suggests UiPath not only offers better growth dynamics but does so at a significantly lower valuation, making it a compelling option for investors seeking enterprise software exposure without the premium price tag.
For those eyeing next-gen automation plays, Pegasystems presents a useful benchmark, but PATH may hold greater upside. Likewise, while ServiceNow continues to dominate the enterprise IT landscape, UiPath’s automation-first strategy offers a differentiated and potentially more scalable growth path.
Performance and Sentiment: Poised for Repricing?
Despite lagging the industry’s 30% rally over the past three months with an 11% gain, PATH hasn’t lost analyst confidence.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for second-quarter fiscal 2026 earnings has held steady, and the stock boasts a Zacks Rank #1 (Strong Buy), a testament to confidence in its operational trajectory.
Image Source: Zacks Investment Research
Investors willing to look past temporary sentiment and focus on fundamentals may find UiPath’s discounted valuation, relentless innovation, and strategic position in enterprise automation too good to pass up. The market may be sleeping on UiPath, but forward-thinking investors shouldn’t.
Image: Bigstock
UiPath Stock Screams Undervalued as Market Overlooks Its RPA Dominance
Key Takeaways
UiPath Inc. (PATH - Free Report) is trading at a discount that growth investors shouldn't ignore. With a forward 12-month price-to-sales (P/S) ratio of just 4.18X — well below the industry average of 5.85X — UiPath looks like a rare undervalued gem in the fast-evolving automation landscape. This disparity isn’t a sign of weakness; rather, it reflects a cautious market that may be underestimating the company’s long-term potential. As a dominant force in robotic process automation (RPA), UiPath is scaling across critical industries like finance, healthcare, and logistics, supported by robust recurring revenue and a rapidly expanding global footprint.
While macro headwinds and tech-sector volatility may be fueling short-term hesitation, PATH’s fundamentals tell a different story. Its deeply integrated developer ecosystem, breadth of automation tools, and enterprise-grade capabilities put it at the center of digital transformation initiatives worldwide. Strategic partnerships with heavyweights like Microsoft and SAP further solidify its relevance and ensure its AI-driven automation suite remains indispensable to large-scale operations.
The Undervalued Challenger Among Giants
Compared to established enterprise players, like ServiceNow (NOW - Free Report) and Pegasystems (PEGA - Free Report) , PATH’s valuation looks strikingly modest. ServiceNow, riding high on profitability and a wide product suite, commands a forward P/S of 13.89X, more than triple UiPath’s. Pegasystems, while similar in automation focus, trades at 4.98X despite slower growth and a narrower automation scope. This suggests UiPath not only offers better growth dynamics but does so at a significantly lower valuation, making it a compelling option for investors seeking enterprise software exposure without the premium price tag.
For those eyeing next-gen automation plays, Pegasystems presents a useful benchmark, but PATH may hold greater upside. Likewise, while ServiceNow continues to dominate the enterprise IT landscape, UiPath’s automation-first strategy offers a differentiated and potentially more scalable growth path.
Performance and Sentiment: Poised for Repricing?
Despite lagging the industry’s 30% rally over the past three months with an 11% gain, PATH hasn’t lost analyst confidence.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for second-quarter fiscal 2026 earnings has held steady, and the stock boasts a Zacks Rank #1 (Strong Buy), a testament to confidence in its operational trajectory.
Investors willing to look past temporary sentiment and focus on fundamentals may find UiPath’s discounted valuation, relentless innovation, and strategic position in enterprise automation too good to pass up. The market may be sleeping on UiPath, but forward-thinking investors shouldn’t.
You can see the complete list of today’s Zacks #1 Rank stocks here.